Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

PTEN deficiency promotes pathological vascular remodeling of human coronary arteries.

Moulton KS, Li M, Strand K, Burgett S, McClatchey P, Tucker R, Furgeson SB, Lu S, Kirkpatrick B, Cleveland JC, Nemenoff RA, Ambardekar AV, Weiser-Evans MC.

JCI Insight. 2018 Feb 22;3(4). pii: 97228. doi: 10.1172/jci.insight.97228. eCollection 2018 Feb 22.

2.

Persistent and Prolonged Parvovirus B19 Viremia in a Pediatric Patient With Acute Lymphoblastic Leukemia.

Fritch Lilla SA, Burgett SE, McGann KA, Wechsler DS.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):e38-40. doi: 10.1093/jpids/piu112. Epub 2014 Nov 23.

PMID:
26407441
3.

Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.

Heath JL, Burgett SE, Gaca AM, Jaffe R, Wechsler DS.

Pediatr Blood Cancer. 2014 Oct;61(10):1874-6. doi: 10.1002/pbc.25100. Epub 2014 May 29.

PMID:
24888336
4.

Wall shear stress measured by phase contrast cardiovascular magnetic resonance in children and adolescents with pulmonary arterial hypertension.

Truong U, Fonseca B, Dunning J, Burgett S, Lanning C, Ivy DD, Shandas R, Hunter K, Barker AJ.

J Cardiovasc Magn Reson. 2013 Sep 13;15:81. doi: 10.1186/1532-429X-15-81.

5.

A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia.

Thornburg CD, Dixon N, Burgett S, Mortier NA, Schultz WH, Zimmerman SA, Bonner M, Hardy KK, Calatroni A, Ware RE.

Pediatr Blood Cancer. 2009 May;52(5):609-15. doi: 10.1002/pbc.21738.

6.

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.

Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE.

Blood. 2007 Aug 1;110(3):1043-7. Epub 2007 Apr 11.

PMID:
17429008
7.

Genome of the bacterium Streptococcus pneumoniae strain R6.

Hoskins J, Alborn WE Jr, Arnold J, Blaszczak LC, Burgett S, DeHoff BS, Estrem ST, Fritz L, Fu DJ, Fuller W, Geringer C, Gilmour R, Glass JS, Khoja H, Kraft AR, Lagace RE, LeBlanc DJ, Lee LN, Lefkowitz EJ, Lu J, Matsushima P, McAhren SM, McHenney M, McLeaster K, Mundy CW, Nicas TI, Norris FH, O'Gara M, Peery RB, Robertson GT, Rockey P, Sun PM, Winkler ME, Yang Y, Young-Bellido M, Zhao G, Zook CA, Baltz RH, Jaskunas SR, Rosteck PR Jr, Skatrud PL, Glass JI.

J Bacteriol. 2001 Oct;183(19):5709-17.

8.

Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells.

Wu S, Wright RA, Rockey PK, Burgett SG, Arnold JS, Rosteck PR Jr, Johnson BG, Schoepp DD, Belagaje RM.

Brain Res Mol Brain Res. 1998 Jan;53(1-2):88-97.

PMID:
9473604
9.

DNA sequence sampling of the Streptococcus pneumoniae genome to identify novel targets for antibiotic development.

Baltz RH, Norris FH, Matsushima P, DeHoff BS, Rockey P, Porter G, Burgett S, Peery R, Hoskins J, Braverman L, Jenkins I, Solenberg P, Young M, McHenney MA, Skatrud PL, Rosteck PR Jr.

Microb Drug Resist. 1998 Spring;4(1):1-9.

PMID:
9533720
10.

The role of neuropeptide Y in the antiobesity action of the obese gene product.

Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, et al.

Nature. 1995 Oct 12;377(6549):530-2.

PMID:
7566151
11.
12.

Sequence similarity between macrolide-resistance determinants and ATP-binding transport proteins.

Schoner B, Geistlich M, Rosteck P Jr, Rao RN, Seno E, Reynolds P, Cox K, Burgett S, Hershberger C.

Gene. 1992 Jun 15;115(1-2):93-6.

PMID:
1612454
13.

Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2.

Sharp JD, White DL, Chiou XG, Goodson T, Gamboa GC, McClure D, Burgett S, Hoskins J, Skatrud PL, Sportsman JR, et al.

J Biol Chem. 1991 Aug 15;266(23):14850-3.

14.

Effects of second-codon mutations on expression of the insulin-like growth factor-II-encoding gene in Escherichia coli.

Cantrell AS, Burgett SG, Cook JA, Smith MC, Hsiung HM.

Gene. 1991 Feb 15;98(2):217-23.

PMID:
2016062
16.
17.

Cloning and expression in Escherichia coli of isopenicillin N synthetase genes from Streptomyces lipmanii and Aspergillus nidulans.

Weigel BJ, Burgett SG, Chen VJ, Skatrud PL, Frolik CA, Queener SW, Ingolia TD.

J Bacteriol. 1988 Sep;170(9):3817-26.

18.
19.

Hygromycin B resistance as dominant selectable marker in yeast.

Kaster KR, Burgett SG, Ingolia TD.

Curr Genet. 1984 Jul;8(5):353-8. doi: 10.1007/BF00419824.

PMID:
24177815
20.

Analysis of a bacterial hygromycin B resistance gene by transcriptional and translational fusions and by DNA sequencing.

Kaster KR, Burgett SG, Rao RN, Ingolia TD.

Nucleic Acids Res. 1983 Oct 11;11(19):6895-911.

21.

Enzymatic degradation by the sera of various animal species of Penicillium chrysogenum mycophage double-stranded RNA.

Douthart RJ, Burgett SG.

Biochem Biophys Res Commun. 1978 Oct 16;84(3):809-15. No abstract available.

PMID:
102327
22.

Isolation of podophyllotoxin from Callitrus drummondii.

KIER LB, FITZGERALD DB, BURGETT S.

J Pharm Sci. 1963 May;52:502-3. No abstract available.

PMID:
14032528

Supplemental Content

Loading ...
Support Center